Factors associated with non-adherence to therapy with warfarin in a population of chronic heart failure patients

Clinical Cardiology

Volumn 31, Issue 1, 2008, Pages 30-34

  Pamboukian, Salpy V ^a,e   Nisar, Imran ^b   Patel, Sheetal ^b   Gu, Liping ^b   McLeod, Mary ^b   Costanzo, Maria Rosa ^c   Heroux, Alain ^d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c Midwest Heart Research Foundation   (United States)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^e NONE   (United States)

Author keywords

Cardiac transplantation; Cardiomyopathy; Heart failure; Myocarditis

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CARDIOMYOPATHY; CHRONIC DISEASE; CIGARETTE SMOKING; COHORT ANALYSIS; COMORBIDITY; DRUG INDICATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HEMATOLOGICAL PARAMETERS; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MYOCARDITIS; PATIENT COMPLIANCE; PATIENT MONITORING; PRIVATE HEALTH INSURANCE; STROKE; THROMBOSIS; TREATMENT OUTCOME;

ANTICOAGULANTS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT REFUSAL; UNITED STATES; WARFARIN;

EID: 38349113420     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20175     Document Type: Article

References (23)

1. National Center for Health Statistics. Deaths: Final Data for 2000. Nat Vital Stat Rep 2002;50:1-120
2. American Heart Association. Heart Disease and Stroke Statistics - 2003 Update. Dallas, TX: American Heart Association, 2002
3. Haynes RB: Introduction. In Compliance in Health Care (Eds. Haynes RB, Taylor DW, Sackett KL), pp 1-7. Baltimore: The Johns Hopkins University Press, 1979
4. Claxton AJ, Cramer J, Pierce C: A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296-1310
5. Bohachick P, Burke LE, Sereika S, Murali S, Dunbar-Jacob J: Adherence to angiotensin-converting enzyme inhibitor therapy for heart failure. Prog Cardiovasc Nurs 2002;17:160-166
6. Ghali JK, Kadakis S, Cooper R, Ferlinz J: Precipitating factors leading to decompensation of heart failure. Arch Intern Med 1988;148:2013-2016
7. Chui MA, Deer M, Bennett SJ, Tu W, Oury S, et al: Association between adherence to diuretic therapy and health care utilization in patients with heart failure. Pharmacotherapy 2003;23:326-332
8. Hope CJ, Wu J, Tu W, Young J, Murray MD: Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. Am J Health Syst Pharm 2004;61:2043-2049
9. N Engl J Med Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. 1991;325:293-302
10. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, et al.: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1196;334:1349-1355
11. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, et al.: The effect of spironolactone on morbidity and mortality in patients with sever heart failure: Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717
12. Balkrishnan R: Predictors of medication adherence in the elderly. Clin Ther 1998;20:764-771
13. Lee JK, Grace KA, Taylor AJ: Effect of a pharmacy care program on medication adherence and persistence, blood pressure and low density lipoprotein concentration. JAMA 2006;296:2563-2571
14. Rasmussen JN, Chong A, Alter DA: Relationship between adherence to evidence-based pharmacotherapy and long term mortality after acute myocardial infarction. JAMA 2007;297:177-186
15. Osterberg L, Blaschke T: Adherence to medication. N Engl J Med 2005;353:487-497
16. Waterman AD, Milligan PE, Bayer L, Banet GA, Gatchel SK, et al.: Effect of warfarin non-adherence on control of the International Normalized Ratio. Am J Health Syst Pharm 2004;61:1258-1264
17. Arnsten JH, Gelfand JM, Singer DE: Determinants of compliance with anticoagulation: a case control study. Am J Med 1997;103:11-17
18. Evangelista LS, Doering LV, Dracup K, Westlake C, Hamilton M, et al.: Compliance behaviors of elderly patients with advanced heart failure. J Cardiovasc Nurs 2003;18:197-206
19. Roe CM, Motheral BR, Teitelbaum F, Rich MW: Compliance with and dosing of angiotensin-converting enzyme inhibitors before and after hospitalization. Am J Health Syst Pharm 2000;57:139-145
20. Ammassari A, Trotta MP, Murri R, Castelli F, Narciso P, et al.: Correlates and predictors of adherence to highly active antiretroviral therapy: overview of the published literature. J Acquir Immune Defic Syndr 2002;31:S123-S127
21. Monane M, Bohn RL, Gurwitz JH: Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender and race. Am J Public Health 1996;86:1805-1808
22. Sharkness CM, Snow DA: The patient's view of hypertension and compliance. Am J Prev Med 1992;8:141-146
23. Miller NH, Hill M, Kottke T, Ockene IS: The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation 1997;95:1085-1090